Tuesday, February 4, 2020
Alanna McEneny-King successfully defended her PhD thesis “Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B “on Jan 23rd, 2020. The thesis work explored the development and application of population pharmacokinetic models in the dose optimization of factor concentrates in hemophilia patients. The thesis also greatly contributed to the Web-Accessible Population Pharmacokinetic Service – Hemophilia (WAPPS-Hemo.org). Congratulations Alanna and all the best in your new position at Alexion Pharmaceuticals in Boston.